Colin South

Colin South is a seasoned executive with extensive experience in the biotechnology industry.1 He served as Vice President Strategy at Zymergen, Inc. from March 2020 to November 2021, based in the Greater Boston area.1

Currently, Colin South is the CEO of ArkeaBio™, a position he has held since January 2022.1 His career history includes several leadership roles:

Previous Positions

• CEO of enEvolv (December 2017 - March 2020)
• Chief Commercial Officer at enEvolv (April 2017 - December 2017)
• CEO of Proterro, Inc. (September 2015 - December 2016)
• CEO of Novogy Inc. (February 2009 - August 2014)
• CTO of Lignol Energy Corporation (May 2009 - September 2011)
• President of Mascoma Corporation (March 2006 - December 2008)

Education

Colin South has a strong educational background in engineering and science:

• Bachelor of Engineering (BE) in Chemical and Process Engineering from the University of Canterbury (1980-1984)
• Master's Degree and PhD from Dartmouth College (1990-1995)1

Colin South is based in Boston, Massachusetts, and has over 500 connections on LinkedIn.1 His career demonstrates a focus on leadership roles in biotechnology and sustainable energy companies, with a particular emphasis on CEO positions in innovative startups.